Mechanisms of Kringle Fragment of Urokinase-induced Vascular Smooth Muscle Cell Migration

Overview

Journal J Surg Res

Specialty General Surgery

Date 2007 Jun 19

PMID 17574041

Citations 1

Authors

Elisa Roztocil

Suzanne M Nicholl

Mark G Davies

Affiliations

Soon will be listed here.

Abstract

Background: Urokinase plasminogen activator (uPA) is involved in vessel remodeling and mediates smooth muscle cell migration. Migration in response to uPA is dependent on both the growth factor binding domain at the aminoterminal end and the kringle (K) domain of the molecule. uPA is readily degraded in vivo into these constitutive domains. The aim of this study was to examine cell signaling during the migration of smooth muscle cell in response to the kringle domain of urokinase.

Materials And Methods: Murine arterial smooth muscle cells were cultured in vitro. Migration assays were performed in the presence of K with and without the plasmin inhibitors (aprotinin and -aminocaproic acid), the Galphai inhibitor Pertussis toxin, the MMP inhibitor (GM6001), the PI3-K inhibitors, Wortmannin and LY294002, and the MAPK inhibitors PD98089 (MEK1 inhibitor) and SB203580 (p38(MAPK) inhibitor). Western blotting was performed for ERK 1/2 and p38(MAPK) phosphorylation after stimulation with K in the presence and absence of the inhibitors. Statistics were analyzed by one-way ANOVA (n = 6).

Results: The kringle domain (K) induced a plasmin-independent, MMP-dependent increase in cell migration (2-fold, P < 0.05) compared to control. This migratory response to K was Galphai mediated and dependent on both ERK 1/2 and p38(MAPK) activation. K induced time-dependent increases in the phosphorylation of ERK 1/2 (3-fold, P < 0.05) and p38(MAPK) (3-fold, P < 0.05). Activation of p38(MAPK) and ERK 1/2 was completely inhibited by the PI3-K inhibitors. We explored a potential role for the epidermal growth factor receptor (EGFR). K induced EGFR phosphorylation and the presence of AG1478, the EGFR inhibitor, inhibited both cell migration and akt activation in response to K.

Conclusion: Kringle domain of uPA induces smooth muscle cell migration through a G-protein-coupled PI3-K-dependent process involving both ERK 1/2 and p38(MAPK) and is mediated in part through EGFR. Defining the differences in response to key molecular domains of uPA is vital to understand its role in vessel remodeling.

Citing Articles

High expression of uPA related to p38MAPK in esophageal cancer indicates poor prognosis.

Liu Q, Li W, Yang S, Liu Z Onco Targets Ther. 2018; 11:8427-8434.

PMID: 30568465 PMC: 6278697. DOI: 10.2147/OTT.S181701.

References

Peng L, Bhatia N, Parker A, Zhu Y, Fay W . Endogenous vitronectin and plasminogen activator inhibitor-1 promote neointima formation in murine carotid arteries. Arterioscler Thromb Vasc Biol. 2002; 22(6):934-9. DOI: 10.1161/01.atv.0000019360.14554.53. View

Calabrese V, Scapagnini G, Ravagna A, Stella A, Butterfield D . Molecular chaperones and their roles in neural cell differentiation. Dev Neurosci. 2002; 24(1):1-13. DOI: 10.1159/000064941. View

Moro L, Dolce L, Cabodi S, Bergatto E, Boeri Erba E, Smeriglio M . Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines. J Biol Chem. 2002; 277(11):9405-14. DOI: 10.1074/jbc.M109101200. View

Hazzalin C, Mahadevan L . MAPK-regulated transcription: a continuously variable gene switch?. Nat Rev Mol Cell Biol. 2002; 3(1):30-40. DOI: 10.1038/nrm715. View

Yamauchi J, Tsujimoto G, Kaziro Y, Itoh H . Parallel regulation of mitogen-activated protein kinase kinase 3 (MKK3) and MKK6 in Gq-signaling cascade. J Biol Chem. 2001; 276(26):23362-72. DOI: 10.1074/jbc.M011752200. View

DAVIES S, Reddy H, Caivano M, Cohen P . Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000; 351(Pt 1):95-105. PMC: 1221339. DOI: 10.1042/0264-6021:3510095. View

Preissner K, Kanse S, May A . Urokinase receptor: a molecular organizer in cellular communication. Curr Opin Cell Biol. 2000; 12(5):621-8. DOI: 10.1016/s0955-0674(00)00141-1. View

OSSOWSKI L, Aguirre-Ghiso J . Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr Opin Cell Biol. 2000; 12(5):613-20. DOI: 10.1016/s0955-0674(00)00140-x. View

Sieg D, Hauck C, Ilic D, Klingbeil C, Schaefer E, Damsky C . FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol. 2000; 2(5):249-56. DOI: 10.1038/35010517. View

10.

Tanski W, Roztocil E, Davies M . Sphingosine-1-phosphate induces G(alphai)-coupled, PI3K/ras-dependent smooth muscle cell migration. J Surg Res. 2002; 108(1):98-106. DOI: 10.1006/jsre.2002.6529. View

11.

Blasi F, Carmeliet P . uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol. 2002; 3(12):932-43. DOI: 10.1038/nrm977. View

12.

Wetzker R, Bohmer F . Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat Rev Mol Cell Biol. 2003; 4(8):651-7. DOI: 10.1038/nrm1173. View

13.

Fegley A, Tanski W, Roztocil E, Davies M . Sphingosine-1-phosphate stimulates smooth muscle cell migration through galpha(i)- and pi3-kinase-dependent p38(MAPK) activation. J Surg Res. 2003; 113(1):32-41. DOI: 10.1016/s0022-4804(03)00120-3. View

14.

Korshunov V, Berk B . Flow-induced vascular remodeling in the mouse: a model for carotid intima-media thickening. Arterioscler Thromb Vasc Biol. 2003; 23(12):2185-91. DOI: 10.1161/01.ATV.0000103120.06092.14. View

15.

Tanski W, Fegley A, Roztocil E, Davies M . Domain-dependent action of urokinase on smooth muscle cell responses. J Vasc Surg. 2004; 39(1):214-22. DOI: 10.1016/s0741-5214(03)01031-0. View

16.

Blasi F, Vassalli J, Dano K . Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J Cell Biol. 1987; 104(4):801-4. PMC: 2114431. DOI: 10.1083/jcb.104.4.801. View

17.

Nakanishi S, Kakita S, Takahashi I, Kawahara K, Tsukuda E, Sano T . Wortmannin, a microbial product inhibitor of myosin light chain kinase. J Biol Chem. 1992; 267(4):2157-63. View

18.

Grobelny D, Poncz L, Galardy R . Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. Biochemistry. 1992; 31(31):7152-4. DOI: 10.1021/bi00146a017. View

19.

Stephens R, Bokman A, Myohanen H, Reisberg T, Tapiovaara H, Pedersen N . Heparin binding to the urokinase kringle domain. Biochemistry. 1992; 31(33):7572-9. DOI: 10.1021/bi00148a019. View

20.

Vlahos C, Matter W, Hui K, Brown R . A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem. 1994; 269(7):5241-8. View